Drop In Jobless Claims Lifts Markets
On the upside
Incyte (Nasdaq: INCY) will license two blood disorder and cancer treatments to Novartis for $150 million upfront and an additional $60 million milestone payment.
Third quarter earnings for J. Crew (NYSE: JCG) more than doubled to surpass expectations as revenue rose.
Although third quarter earnings for Tiffany & Co. (NYSE: TIF) eased, the results topped estimates and the jewelry retailer lifted its full year outlook.
On the downside
Coldwater Creek (Nasdaq: CWTR) blamed a significant tax charge for widening third quarter losses.
Dataram (Nasdaq: DRAM) widened second quarter losses even as revenue increased.
India's Central Bureau of Investigation filed more charges against ten people accused of accounting fraud at Satyam Computer (NYSE: SAY).
In the broad market, advancing issues outpaced decliners by a margin of more than 9to 7 on the NYSE while decliners edged out advancers by 10 to 9 on Nasdaq. The Russell 2000 which tracks small cap stocks eased a fraction to 592.

